| Add Advanced Drug Delivery Technologies Ltd. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110274819 | Oral preparation with controlled release - A pharmaceutical pellet is disclosed, comprising a spherical core containing active ingredient with a smooth surface and a coating on the core which controls the release of the active ingredient in a pH-independent manner. With such a pellet the release of the active ingredient can follow a profile with a lag phase of 60 minutes to 840 minutes, a proportion of 5 wt. % or less of the active ingredient being released during the lag phase. The active ingredient can furthermore be released from the pellet with a profile such that after the lag phase the release of the active ingredient amounts to between 3 and 25 wt. % per hour. | 11-10-2011 |
| 20110268798 | ORALLY DISNTEGRATING TABLETS FOR THE TREATMENT OF PAIN - An orally disintegrating tablet comprising acetylsalicylic acid, acetaminophen and caffeine and one or more pharmaceutically acceptable excipients. | 11-03-2011 |
| 20100080849 | PELLETS CONTAINING A PHARMACEUTICAL SUBSTANCE, METHOD FOR THE PRODUCTION THEREOF AND USE OF THE SAME - The invention relates to pellets containing a pharmaceutical substance with a breaking strength of more than 0.001 newton, method of production thereof and pharmaceutical preparations based on said pellets. | 04-01-2010 |
| 20090311319 | Oral Preparation With Controlled Release - Abstract Oral preparation with controlled release A pharmaceutical pellet is provided, comprising a spherical core containing the active substance with a smooth surface and a coating on the core, which controls pH-independent release of the active substance. With a pellet of this kind, the release of the active substance may follow a profile with a lag-phase from 60 minutes to 840 minutes, where during the lag-phase a proportion of 5 wt. % or less of the active substance is released. Furthermore, the active substance may be released from the pellet with a profile such that, after the lag-phase, the release of the active substance is between and 25 wt. % per hour. The active substance is a metoprolol salt. | 12-17-2009 |
